$BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in BIOCRYST PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOCRYST PHARMACEUTICALS INC for free.

CIK Number: 0000882796
IRS Number: 621413174
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BCRX
Company Address: 4505 EMPEROR BOULEVARD SUITE 200 DURHAM 27703

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC.

Market Capitalization: $427.06M
Prev close: $5.67
Average Daily Volume: 981,787
Days Low: $5.55
Year Low: $1.63
Year High: $7.56

BIOCRYST PHARMACEUTICALS INC Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
ASELAGE STEVEDirector6,67237,830shares bought: 6,672 / shares sold: 0 STRONG BUYSep 04 20192 months ago
HEGGIE THERESADirector1,6729,480shares bought: 1,672 / shares sold: 0 BUYSep 04 20192 months ago
Hutson Nancy JDirector43,046244,071shares bought: 21,184 / shares sold: 0 STRONG BUYSep 04 20192 months ago
INGRAM ROBERT ADirector28,088159,259shares bought: 31,004 / shares sold: 0 STRONG BUYSep 04 20192 months ago
Thackray Helen M.Director00Sep 24 201925 days ago

View all BIOCRYST PHARMACEUTICALS INC insiders.

BIOCRYST PHARMACEUTICALS INC Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 24 2019BCRXBIOCRYST PHARMACEU ...Thackray Helen M.DirectorOption ExerciseA2.8640,000114,40040,000
Sep 04 2019BCRXBIOCRYST PHARMACEU ...HEGGIE THERESADirectorGrantA2.991,6724,9991,6720 to 1.7 K
Sep 04 2019BCRXBIOCRYST PHARMACEU ...ASELAGE STEVEDirectorGrantA2.991,6724,9996,6725 K to 6.7 K (+33.44 %)
Sep 04 2019BCRXBIOCRYST PHARMACEU ...Hutson Nancy JDirectorGrantA2.993,3449,99943,04639.7 K to 43 K (+8.42 %)
Sep 04 2019BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorGrantA2.996,27018,74728,08821.8 K to 28.1 K (+28.74 %)
Jul 03 2019BCRXBIOCRYST PHARMACEU ...Sniecinski MeganChief Business Offi ...Option ExerciseA3.71500,0001,855,000500,000
May 31 2019BCRXBIOCRYST PHARMACEU ...LEE KENNETH B JRDirectorOption ExerciseA2.9130,00087,30030,000
May 31 2019BCRXBIOCRYST PHARMACEU ...INGRAM ROBERT ALEXANDERDirectorOption ExerciseA2.9130,00087,30030,000
May 31 2019BCRXBIOCRYST PHARMACEU ...Hutson Nancy JDirectorOption ExerciseA2.9130,00087,30030,000
May 31 2019BCRXBIOCRYST PHARMACEU ...HEGGIE THERESADirectorOption ExerciseA2.9130,00087,30030,000
May 31 2019BCRXBIOCRYST PHARMACEU ...ABERCROMBIE GEORGE BDirectorOption ExerciseA2.9130,00087,30030,000
May 24 2019BCRXBIOCRYST PHARMACEU ...ASELAGE STEVEDirectorBuyP3.573,00010,7105,0002 K to 5 K (+150.00 %)
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...Option ExerciseM1.424,7506,74561,000
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.452,50018,625125,176127.7 K to 125.2 K (-1.96 %)
May 20 2019BCRXBIOCRYST PHARMACEU ...STAAB THOMAS R IISenior Vice Preside ...SellS7.727,25055,970127,676134.9 K to 127.7 K (-5.37 %)

View all BIOCRYST PHARMACEUTICALS INC insider transactions.